‘ to diagnose. derived. priority’is the motto coined by Gilead Sciences Pharmaceuticals, an expert in the treatment of HIV and AIDS. hepatitis Following the launch of the fellowship program ALL4LIVER 2023, the program aims to support those who advance diagnosis, improve medical care and prioritization Approaches to tackling viral hepatitis on the public health agenda.
Senior Vice President of Science Public Affairs, Gilead Sciences, Alex Calonparis “Gilead’s expanded fellowship program, ALL4LIVER 2023, reflects our commitment to addressing viral hepatitis as an urgent global challenge and creating a healthier future for all people with liver disease.”
Demonstrates our commitment to addressing the urgent global challenge of viral hepatitis
In this way, the ALL4LIVER project will support initiatives all around the world, for hepatitis C, B, or D (except in the United States).application will be Revise International Committee of Independent Experts in the Field of Viral Hepatitis
a member of review committee Because of its role in viral hepatitis research, public health or patient advocacy.
The World Health Organization (WHO) set a clear goal in 2016, “by 2030 to eliminate viral hepatitis because they have become a threat to public health”. However, with only seven years left to achieve this goal, it will take urgently Take a more global approach from all areas related to viral hepatitis.
“Now more than ever, there is a need for ALL4LIVER Scholarship Gilead is critical to ensuring that viral hepatitis continues to receive the attention it deserves, and we continue to develop innovative strategies to eliminate it. “ DanjumaCamron Ada President of the World Hepatitis Alliance.
Ensuring viral hepatitis continues to receive the attention it deserves is critical
For more than two decades, Gilead has been working to improve the quality of life for people living with viral hepatitis while focusing on helping achieve the purpose of eliminating through community organizations.For this, please support Innovation Program Addressing the unmet needs of people living with viral hepatitis around the world.
through empowerment community organizationour goal is to promote liver health and help make the elimination of viral hepatitis a reality by 2030,” he said. Alex Caronparis.